OBJECTIVE: The ATP-binding cassette transporter A1 (ABCA1) is a major regulator of macrophage cholesterol efflux and protects cells from excess intracellular cholesterol accumulation; however, the mechanism involved in posttranscriptional regulation of ABCA1 is poorly understood. We previously showed that microRNA-33 (miR-33) is 1 regulator. Here, we investigated the potential contribution of other microRNAs (miRNAs) to posttranscriptional regulation of ABCA1 and macrophage cholesterol efflux. METHODS AND RESULTS: We performed a bioinformatic analysis for identifying miRNA target prediction sites in ABCA1 gene and an unbiased genome-wide screen to identify miRNAs modulated by cholesterol excess in mouse peritoneal macrophages. Quantitative real-time reverse transcription-polymerase chain reaction confirmed that miR-758 is repressed in cholesterol-loaded macrophages. Under physiological conditions, high dietary fat excess in mice repressed miR-758 both in peritoneal macrophages and, to a lesser extent, in the liver. In mouse and human cells in vitro, miR-758 repressed the expression of ABCA1, and conversely, the inhibition of this miRNA by using anti-miR-758 increased ABCA1 expression. In mouse cells, miR-758 reduced cellular cholesterol efflux to apolipoprotein A1 (apoA1), and anti-miR-758 increased it. miR-758 directly targets the 3'-untranslated region of Abca1 as assessed by 3'-untranslated region luciferase reporter assays. Interestingly, miR-758 is highly expressed in the brain, where it also targets several genes involved in neurological functions, including Slc38a1, Ntm, Epha7, and Mytl1. CONCLUSION: We identified miR-758 as a novel miRNA that posttranscriptionally controls ABCA1 levels in different cells and regulates macrophage cellular cholesterol efflux to apoA1, opening new avenues to increase apoA1 and raise high-density lipoprotein levels.
OBJECTIVE: The ATP-binding cassette transporter A1 (ABCA1) is a major regulator of macrophage cholesterol efflux and protects cells from excess intracellular cholesterol accumulation; however, the mechanism involved in posttranscriptional regulation of ABCA1 is poorly understood. We previously showed that microRNA-33 (miR-33) is 1 regulator. Here, we investigated the potential contribution of other microRNAs (miRNAs) to posttranscriptional regulation of ABCA1 and macrophage cholesterol efflux. METHODS AND RESULTS: We performed a bioinformatic analysis for identifying miRNA target prediction sites in ABCA1 gene and an unbiased genome-wide screen to identify miRNAs modulated by cholesterol excess in mouse peritoneal macrophages. Quantitative real-time reverse transcription-polymerase chain reaction confirmed that miR-758 is repressed in cholesterol-loaded macrophages. Under physiological conditions, high dietary fat excess in mice repressed miR-758 both in peritoneal macrophages and, to a lesser extent, in the liver. In mouse and human cells in vitro, miR-758 repressed the expression of ABCA1, and conversely, the inhibition of this miRNA by using anti-miR-758 increased ABCA1 expression. In mouse cells, miR-758 reduced cellular cholesterol efflux to apolipoprotein A1 (apoA1), and anti-miR-758 increased it. miR-758 directly targets the 3'-untranslated region of Abca1 as assessed by 3'-untranslated region luciferase reporter assays. Interestingly, miR-758 is highly expressed in the brain, where it also targets several genes involved in neurological functions, including Slc38a1, Ntm, Epha7, and Mytl1. CONCLUSION: We identified miR-758 as a novel miRNA that posttranscriptionally controls ABCA1 levels in different cells and regulates macrophage cellular cholesterol efflux to apoA1, opening new avenues to increase apoA1 and raise high-density lipoprotein levels.
Authors: S M Clee; J J Kastelein; M van Dam; M Marcil; K Roomp; K Y Zwarts; J A Collins; R Roelants; N Tamasawa; T Stulc; T Suda; R Ceska; B Boucher; C Rondeau; C DeSouich; A Brooks-Wilson; H O Molhuizen; J Frohlich; J Genest; M R Hayden Journal: J Clin Invest Date: 2000-11 Impact factor: 14.808
Authors: Suzanne E Wahrle; Hong Jiang; Maia Parsadanian; Justin Legleiter; Xianlin Han; John D Fryer; Tomasz Kowalewski; David M Holtzman Journal: J Biol Chem Date: 2004-07-21 Impact factor: 5.157
Authors: Veronica Hirsch-Reinshagen; Steven Zhou; Braydon L Burgess; Lise Bernier; Sean A McIsaac; Jeniffer Y Chan; Gavin H Tansley; Jeffrey S Cohn; Michael R Hayden; Cheryl L Wellington Journal: J Biol Chem Date: 2004-07-21 Impact factor: 5.157
Authors: Nan Wang; Wengen Chen; Patrick Linsel-Nitschke; Laurent O Martinez; Birgit Agerholm-Larsen; David L Silver; Alan R Tall Journal: J Clin Invest Date: 2003-01 Impact factor: 14.808
Authors: Kris Richardson; Jennifer A Nettleton; Noemi Rotllan; Toshiko Tanaka; Caren E Smith; Chao-Qiang Lai; Laurence D Parnell; Yu-Chi Lee; Jari Lahti; Rozenn N Lemaitre; Ani Manichaikul; Margaux Keller; Vera Mikkilä; Julius Ngwa; Frank J A van Rooij; Christie M Ballentyne; Ingrid B Borecki; L Adrienne Cupples; Melissa Garcia; Albert Hofman; Luigi Ferrucci; Dariush Mozaffarian; Mia-Maria Perälä; Olli Raitakari; Russell P Tracy; Donna K Arnett; Stefania Bandinelli; Eric Boerwinkle; Johan G Eriksson; Oscar H Franco; Mika Kähönen; Michael Nalls; David S Siscovick; Denise K Houston; Bruce M Psaty; Jorma Viikari; Jacqueline C M Witteman; Mark O Goodarzi; Terho Lehtimäki; Yongmei Liu; M Carola Zillikens; Yii-Der I Chen; André G Uitterlinden; Jerome I Rotter; Carlos Fernandez-Hernando; Jose M Ordovas Journal: Am J Hum Genet Date: 2012-12-13 Impact factor: 11.025